8-K - Regeneron Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

. The information included or incorporated in this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities E

Financial Results

9.01

Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release, dated January 30, 2026, Reporting Fourth Quarter and Full Year 2025 Financial and Operating

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EXHIBIT 99.1